Skip to main content
. Author manuscript; available in PMC: 2022 Apr 15.
Published in final edited form as: Cancer Res. 2021 Aug 16;81(20):5296–5310. doi: 10.1158/0008-5472.CAN-21-0757

Figure 4. Analysis of apoptosis and ROS production in T cells treated with LA or OA in vitro.

Figure 4.

(A, B) Splenocytes from normal wild type mice were treated with indicated concentrations of LA, OA or BSA for 20 hours. FA-induced cell death of CD8+ (A) and CD4+ (B) T cells were analyzed by flow cytometric annexin V staining.

(C, D) Splenocytes were treated with 400 μM LA, OA or BSA control in the presence of plate-bound ant-CD3(1μg/ml) and anti-CD28(1μg/ml) for 24 hours, PMA/ionomycin and BFA were added at the last 6 hours. Percentages of TNF-α production in CD8+(C) or CD4+ (D) T cells were measured by intracellular staining.

(E, F) Analysis of cell death of CD4+ or CD8+ T cells treated with BSA, LA, or OA (400μM) for 20 hours in the presence or absence of z-Vad, Ferrostatin-1 or Necrostatin-1 (1μM) by flow cytometry.

(G) Confocal microscopy analysis of ROS production as shown by DCF (green) in sorted T cells (DAPI, blue for nuclei) treated with BSA, LA or OA (400μM) for 30 mins.

(H, I) Measurement of fluorescent intensity of DCF in CD8+ (H) or CD4+ (I) T cells treated with 400μM LA, OA or BSA for 30 mins by flow cytometry.

(J, K) Cell death analysis of CD8+ (J) or CD4+ (K) T cells pretreated with DPI or NAC for 15mins before addition of BSA, LA, or OA (400μM) for 20 hours by flow cytometry.

Results represent 3 independent experiments. Data are shown as mean ± SEM (* p<0.05, *** p<0.001). Also see Figure S3.